Corcept Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Corcept Therapeutics Inc's ROI in the second quarter of 2026?
Corcept Therapeutics Inc achieved a return on average invested assets (ROI) of 7.96 % in its second quarter of 2026, which is below Corcept Therapeutics Inc's average return on investment, which stands at 9.96%.

ROI has improved compared to 7.06% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 6 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1201 to 1205.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	0.16 %	-1.13 %	6.01 %	15.94 %	26.26 %
Y / Y Net Income Change TTM	-58.93 %	-64.77 %	-12.52 %	27.94 %	275.85 %
Investment (TTM) in Millions	735	666	671	651	657
Return On Investment (TTM)	7.96 %	7.06 %	14.64 %	15.44 %	19.42 %
CORT's Overall Ranking	# 1205	# 1201	# 356	# 404	# 247
Seq. Investment Change TTM	2.94 %	-1.41 %	-1.08 %	-0.25 %	1.62 %
Seq. Net Income Change TTM	16.13 %	-52.45 %	-6.21 %	-20.71 %	-0.38 %
Net Income (TTM) in Millions	54	47	98	105	132

CORT Company Profile >> Back to CORT Roi Comparisons >> See Annual CORT Return On Investment

Return On Investment CORT's Ranking
Within:	No.
Industry	# 1
Sector	# 7
Overall	# 1205

Return On Investment Statistics
High	Average	Low
131.42 %	9.96 %	-109.71 %
(Dec 31 2017)		(Dec 31 2014)

News about Corcept Therapeutics Inc Return on Investment ROI

Corcept Therapeutics Appoints Roberto Vieira as President, Oncology amidst Recent Stock Dip

January 29, 2024

Combining Articles:
Corcept Therapeutics Incorporated, a leading commercial-stage company specializing in the discovery and development of medications to address severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating cortisol hormone effects, has appointed Roberto Vieira as the new President of Oncology. The announcement was made on January 29, 2024, by Joseph K. Belanoff, MD, Corcept s Chief Executive Officer.
Vieira, an experienced professional in the field, will report directly to Dr. Belanoff and join Corcept s Executive Team. This strategic move aims to bolster the company s efforts in the oncology sector. As an emerging area of focus within Corcept s diverse portfolio, having a dedicated leader in Oncology will enhance their capabilities and drive progress in developing innovative treatments.

Financial Statements
Corcept Therapeutics Inc's II. Quarter Investments	$ 735 Millions	CORT's Balance sheet
Corcept Therapeutics Inc's II. Quarter Income	$ 42 Millions	Quarterly CORT's Income Statement
CORT's Income by Division		See CORT's Income by Division

CORT Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	671	700	517	511	376
Y / Y Investment Growth	-4.17 %	35.35 %	1.19 %	35.81 %	-28.24 %
Net Income in Millions	98	140	105	101	113
Y / Y Net Income Growth	-29.74 %	32.45 %	4.15 %	-9.98 %	6.13 %
Annual Return On Investment	14.64 %	19.97 %	20.4 %	19.82 %	29.91 %

Annual Roi Comment

In the fiscal year 2025 ROI decreased relative to the previous year to 14.64 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CORT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CORT's Competitors
Subscribers only: Roi for Corcept Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for CORT's Customers

Other Ratios
CORT's Roa	CORT's Inventory Turnover Ratio	CORT's Growth Rates	CORT's Dividend Statistics
	CORT's Profitability Ratios	CORT's Asset Turnover Ratio	CORT's Dividend Growth
CORT's Roe	CORT's Valuation Ratios	CORT's Financial Strength Ratios	CORT's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector	ROI
Eton Pharmaceuticals Inc	21.31 %
Dexcom Inc	20.98 %
Healthcare Services Group Inc	20.93 %
Arcutis Biotherapeutics Inc	20.77 %
Chemed Corporation	20.13 %
Resmed Inc	20.01 %
Halozyme Therapeutics Inc	19.99 %
Vertex Pharmaceuticals Inc	19.97 %
Agilent Technologies inc	19.84 %
Illumina Inc	19.61 %
Puma Biotechnology Inc	19.60 %
United Therapeutics Corporation	19.53 %
Zoetis Inc	19.44 %
Krystal Biotech Inc	19.16 %
Carlisle Companies Incorporated	18.88 %
Neurocrine Biosciences Inc	17.51 %
Intuitive Surgical Inc	17.11 %
Theravance Biopharma inc	17.10 %
Standard Biotools Inc	16.38 %
Inspire Medical Systems inc	16.34 %
Aveanna Healthcare Holdings Inc	16.32 %
Harmony Biosciences Holdings inc	15.85 %
Entera Bio Ltd	15.84 %
Nephros Inc	15.31 %
West Pharmaceutical Services Inc	15.29 %
Progyny Inc	15.25 %
Biolife Solutions Inc	14.83 %
Sbc Medical Group Holdings Incorporated	14.78 %
Spero Therapeutics Inc	14.54 %
Insulet Corporation	14.30 %

Date modified: 2026-08-13T08:10:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.